Different metabolic responses to PI3K inhibition in NSCLC cells harboring wild-type and G12C mutant KRAS.
Caiola, Elisa
Different metabolic responses to PI3K inhibition in NSCLC cells harboring wild-type and G12C mutant KRAS. [electronic resource] - Oncotarget Aug 2016 - 51462-51472 p. digital
Publication Type: Journal Article
1949-2553
10.18632/oncotarget.9849 doi
Amino Acid Substitution
Carcinoma, Non-Small-Cell Lung--genetics
Cells, Cultured
Cysteine--genetics
Glycine--genetics
Humans
Imidazoles--pharmacology
Lung Neoplasms--genetics
Mutation, Missense
Phosphoinositide-3 Kinase Inhibitors
Protein Kinase Inhibitors--pharmacology
Proto-Oncogene Proteins p21(ras)--genetics
Quinolines--pharmacology
Signal Transduction--drug effects
Different metabolic responses to PI3K inhibition in NSCLC cells harboring wild-type and G12C mutant KRAS. [electronic resource] - Oncotarget Aug 2016 - 51462-51472 p. digital
Publication Type: Journal Article
1949-2553
10.18632/oncotarget.9849 doi
Amino Acid Substitution
Carcinoma, Non-Small-Cell Lung--genetics
Cells, Cultured
Cysteine--genetics
Glycine--genetics
Humans
Imidazoles--pharmacology
Lung Neoplasms--genetics
Mutation, Missense
Phosphoinositide-3 Kinase Inhibitors
Protein Kinase Inhibitors--pharmacology
Proto-Oncogene Proteins p21(ras)--genetics
Quinolines--pharmacology
Signal Transduction--drug effects